ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Evaluation of Legionella PCR Techniques for the Routine Diagnosis of Legionellosis

This study is currently recruiting participants.
Verified by Centre Hospitalier Universitaire de Saint Etienne, April 2008

Sponsors and Collaborators: Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France
Information provided by: Centre Hospitalier Universitaire de Saint Etienne
ClinicalTrials.gov Identifier: NCT00452153
  Purpose

The validity of molecular techniques for the diagnosis of legionellosis is not known. Although PCR can detect Legionella pneumophila (responsible for 80% of legionellosis) and other Legionella species, this test is not recommended in standard guidelines to assess this diagnostic, by contrast to culture of sputum, serology and urine antigen. The aim of this study is to evaluate Legionella PCR techniques, performed directly onto the sputum aspirates, for the routine diagnosis of pneumonia in adults' patients admitted to hospital. This study implicates 3 University hospitals (Lyon, Grenoble and Saint-Etienne) in collaboration with the French reference center of legionellosis for a previous duration of one year. In addition to the usual diagnostic tests that are performed when pneumonia is suspected, real-time PCR will be added for the detection and differentiation of Legionella. Hypothesizing the inclusion of 1000 pneumonia in this study, the predictable number of newly-detected legionellosis will be approximately 60 to 70 cases. According to a predefined algorithm, cases of legionellosis will be classified as definite or probable. Sensitivity and specificity of the real-time PCR will be calculated according to this classification. This study is intended to validate real-time PCR as a tool for the rapid diagnosis of legionellosis, allowing to optimize the antibiotic treatment of pneumonia. PCR techniques can also contribute to the better detection and differentiation of Legionella sp infections that are not documented accurately by routine microbiologic tests.


Condition Intervention
Legionellosis
Procedure: instillation of physiological saline

MedlinePlus related topics:   Pneumonia   

ChemIDplus related topics:   Sodium chloride   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Diagnostic, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study
Official Title:   Evaluation of Legionella PCR Techniques for the Routine Diagnosis of Legionellosis

Further study details as provided by Centre Hospitalier Universitaire de Saint Etienne:

Primary Outcome Measures:
  • Definite or probable legionellosis

Secondary Outcome Measures:
  • Definite legionellosis
  • Probable legionellosis
  • Possible legionellosis

Estimated Enrollment:   913
Study Start Date:   March 2007
Estimated Study Completion Date:   July 2008
Estimated Primary Completion Date:   July 2008 (Final data collection date for primary outcome measure)

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • > 18 years
  • Written informed consent
  • Patient affiliated to social insurance
  • Community acquired or nosocomial pneumonia

Exclusion Criteria:

  • No sputum aspirate
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00452153

Contacts
Contact: Philippe Berthelot, MD PhD     00 33 4 77 12 05 92     philippe.berthelot@chu-st-etienne.fr    
Contact: Florence Grattard, MD     00 33 4 77 82 81 05     florence.grattard@chu-st-etienne.fr    

Locations
France
Urgency unit CHU Saint-Etienne     Recruiting
      SAINT-ETIENNE, France, 42055
      Contact: Alain VIALLON, MD     00 33 4 77 12 05 87     alain.viallon@chu-st-etienne.fr    
      Sub-Investigator: Alain Viallon, MD            
      Sub-Investigator: Olivier Marjollet, MD            
      Sub-Investigator: Yann Leveques, MD            
      Sub-Investigator: Frédéric Garcia, MD            
      Sub-Investigator: Marie Cheynet, MD            
      Sub-Investigator: Floriane Robert, MD            
      Sub-Investigator: Lionel Cotte, MD            
      Sub-Investigator: Christophe Berger, MD            
      Sub-Investigator: Anaclet Ngameni, MD            
      Sub-Investigator: Matthieu Belin, MD            
      Sub-Investigator: Alexis Rousset, MD            
      Sub-Investigator: Pantea Hafezi-Moghaddam, MD            
      Sub-Investigator: Valerie Pouzet, MD            
      Sub-Investigator: Baptiste Ehret, MD            
Pneumology unit CHU de Saint-Etienne     Recruiting
      SAINT-ETIENNE, France, 42055
      Contact: Jean-Michel Vergnon, MD PhD     00 33 4 77 82 83 14     jean-michel.vergnon@chu-st-etienne.fr    
      Sub-Investigator: Jean-Michel Vergnon, MD PhD            
      Sub-Investigator: Isabelle Court-Fortune, MD            
      Sub-Investigator: Pierre Fournel, MD            
      Sub-Investigator: Sophie Bayle, MD            
      Sub-Investigator: Sandra Morgado, MD            
Infectious Disease unit CHU de Saint-Etienne     Recruiting
      SAINT-ETIENNE, France, 42055
      Sub-Investigator: Celine Cazorla, MD            
      Sub-Investigator: Anne Fresard, MD            
      Sub-Investigator: François Durand, MD            
      Sub-Investigator: Pascal Fascia, MD            
      Principal Investigator: Philippe Berthelot, MD PhD            
      Sub-Investigator: Frederic Lucht, MD PhD            
      Sub-Investigator: Franck-Olivier Mallaval, MD            
Reanimation unit - Hopital Bellevue - CHU de Saint-Etienne     Recruiting
      SAINT-ETIENNE, France, 42055
      Sub-Investigator: Fabrice Zeni, MD PhD            
      Sub-Investigator: Christophe Venet, MD            
      Sub-Investigator: Monique Bertrand, MD            
      Sub-Investigator: Pierre Gery, MD            
      Sub-Investigator: Dominique Page, MD            
Reanimation unit - Hôpital NORD - CHU de Saint-Etienne     Recruiting
      SAINT-ETIENNE, France, 42055
      Sub-Investigator: Christian Auboyer, MD PhD            
      Sub-Investigator: David Rosay, MD            
      Sub-Investigator: Richard Jospe, MD            
      Sub-Investigator: Jerome Morel, MD            
      Sub-Investigator: Alain Dumont, MD            
HMU CHU Saint-Etienne     Recruiting
      SAINT-ETIENNE, France, 42055
      Sub-Investigator: Bernard Tardy, MD            
      Sub-Investigator: Yves Pages, MD            
      Sub-Investigator: Eric Diconne, MD            
      Sub-Investigator: Stephane Guyomarc'h, MD            

Sponsors and Collaborators
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Investigators
Principal Investigator:     Philippe Berthelot, PU-PH     CHU-Saint-Etienne    
  More Information


Publications:
Squier CL, Stout JE, Krsytofiak S, McMahon J, Wagener MM, Dixon B, Yu VL. A proactive approach to prevention of health care-acquired Legionnaires' disease: the Allegheny County (Pittsburgh) experience. Am J Infect Control. 2005 Aug;33(6):360-7.
 
Decludt B, Campese C, Lacoste M, Che D, Jarraud S, Etienne J. Clusters of travel associated legionnaires' disease in France, September 2001- August 2003. Euro Surveill. 2004 Feb;9(2):12-3.
 
Grattard F, Berthelot P, Reyrolle M, Ros A, Etienne J, Pozzetto B. Molecular typing of nosocomial strains of Legionella pneumophila by arbitrarily primed PCR. J Clin Microbiol. 1996 Jun;34(6):1595-8.
 
Aurell H, Etienne J, Forey F, Reyrolle M, Girardo P, Farge P, Decludt B, Campese C, Vandenesch F, Jarraud S. Legionella pneumophila serogroup 1 strain Paris: endemic distribution throughout France. J Clin Microbiol. 2003 Jul;41(7):3320-2.
 
Gaia V, Fry NK, Afshar B, Luck PC, Meugnier H, Etienne J, Peduzzi R, Harrison TG. Consensus sequence-based scheme for epidemiological typing of clinical and environmental isolates of Legionella pneumophila. J Clin Microbiol. 2005 May;43(5):2047-52.
 
Wang EE, Manson B, Corey M, Bernard K, Prober CG. False positivity of Legionella serology in patients with cystic fibrosis. Pediatr Infect Dis J. 1987 Mar;6(3):256-9.
 
Plouffe JF, File TM Jr, Breiman RF, Hackman BA, Salstrom SJ, Marston BJ, Fields BS. Reevaluation of the definition of Legionnaires' disease: use of the urinary antigen assay. Community Based Pneumonia Incidence Study Group. Clin Infect Dis. 1995 May;20(5):1286-91.
 
Helbig JH, Uldum SA, Bernander S, Luck PC, Wewalka G, Abraham B, Gaia V, Harrison TG. Clinical utility of urinary antigen detection for diagnosis of community-acquired, travel-associated, and nosocomial legionnaires' disease. J Clin Microbiol. 2003 Feb;41(2):838-40.
 
Grattard F, Ginevra C, Riffard S, Ros A, Jarraud S, Etienne J, Pozzetto B. Analysis of the genetic diversity of Legionella by sequencing the 23S-5S ribosomal intergenic spacer region: from phylogeny to direct identification of isolates at the species level from clinical specimens. Microbes Infect. 2006 Jan;8(1):73-83. Epub 2005 Aug 8.
 
Hayden RT, Uhl JR, Qian X, Hopkins MK, Aubry MC, Limper AH, Lloyd RV, Cockerill FR. Direct detection of Legionella species from bronchoalveolar lavage and open lung biopsy specimens: comparison of LightCycler PCR, in situ hybridization, direct fluorescence antigen detection, and culture. J Clin Microbiol. 2001 Jul;39(7):2618-26.
 
Templeton KE, Scheltinga SA, Sillekens P, Crielaard JW, van Dam AP, Goossens H, Claas EC. Development and clinical evaluation of an internally controlled, single-tube multiplex real-time PCR assay for detection of Legionella pneumophila and other Legionella species. J Clin Microbiol. 2003 Sep;41(9):4016-21.
 
Welti M, Jaton K, Altwegg M, Sahli R, Wenger A, Bille J. Development of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae in respiratory tract secretions. Diagn Microbiol Infect Dis. 2003 Feb;45(2):85-95.
 
Reischl U, Linde HJ, Lehn N, Landt O, Barratt K, Wellinghausen N. Direct detection and differentiation of Legionella spp. and Legionella pneumophila in clinical specimens by dual-color real-time PCR and melting curve analysis. J Clin Microbiol. 2002 Oct;40(10):3814-7.
 
Ginevra C, Barranger C, Ros A, Mory O, Stephan JL, Freymuth F, Joannes M, Pozzetto B, Grattard F. Development and evaluation of Chlamylege, a new commercial test allowing simultaneous detection and identification of Legionella, Chlamydophila pneumoniae, and Mycoplasma pneumoniae in clinical respiratory specimens by multiplex PCR. J Clin Microbiol. 2005 Jul;43(7):3247-54.
 
Helbig JH, Bernander S, Castellani Pastoris M, Etienne J, Gaia V, Lauwers S, Lindsay D, Luck PC, Marques T, Mentula S, Peeters MF, Pelaz C, Struelens M, Uldum SA, Wewalka G, Harrison TG. Pan-European study on culture-proven Legionnaires' disease: distribution of Legionella pneumophila serogroups and monoclonal subgroups. Eur J Clin Microbiol Infect Dis. 2002 Oct;21(10):710-6. Epub 2002 Oct 18.
 
Wellinghausen N, Frost C, Marre R. Detection of legionellae in hospital water samples by quantitative real-time LightCycler PCR. Appl Environ Microbiol. 2001 Sep;67(9):3985-93.
 
Woodhead M. Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. Eur Respir J Suppl. 2002 Jul;36:20s-27s. Review.
 

Study ID Numbers:   0601072
First Received:   March 26, 2007
Last Updated:   April 2, 2008
ClinicalTrials.gov Identifier:   NCT00452153
Health Authority:   France: Ministry of Health

Keywords provided by Centre Hospitalier Universitaire de Saint Etienne:
legionellosis  
diagnosis of legionellosis  
PCR  

Study placed in the following topic categories:
Bacterial Infections
Legionellosis
Respiratory Tract Diseases
Respiratory Tract Infections
Gram-Negative Bacterial Infections

ClinicalTrials.gov processed this record on October 20, 2008




Links to all studies - primarily for crawlers